In the news | 2nd Aug 2022
Approaching the BioPharma data lifecycle in an integrated manner
Advances in digital technology offer an attractive solution to biopharmaceutical companies looking to deliver a new generation of increasingly complex therapies. While artificial intelligence and automation such as the Industry 4.0 movement have the potential to reduce time and cost, modernized data governance is essential to ensure a solid foundation of data integrity and regulatory compliance to meet these objectives.
Read about an integrated approach to the BioPharma data lifecycle in this article by Scott Weiss, Vice President of Business Development and Open Innovation, IDBS, published in PharmTech.com.